Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Net Block

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Net Block History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Net Block ₹4,245 Cr₹3,583 Cr₹1,659 Cr₹1,594 Cr₹1,399 Cr

What is the latest Net Block ratio of MANKIND PHARMA ?

The latest Net Block ratio of MANKIND PHARMA is ₹4,245 Cr based on Mar2023 Consolidated results.
Year Net Block
Mar2023₹4,245 Cr
Mar2022₹3,583 Cr
Mar2021₹1,659 Cr
Mar2020₹1,594 Cr
Mar2019₹1,399 Cr

How is Net Block of MANKIND PHARMA Trending?

Years Net Block % Change
Mar2023 ₹4,245 Cr
18.49
Mar2022 ₹3,583 Cr
115.97
Mar2021 ₹1,659 Cr
4.07
Mar2020 ₹1,594 Cr
13.90
Mar2019 ₹1,399 Cr -

Compare Net Block of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹83,809.5 Cr -6.5% -7.6% 57% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹368,598.0 Cr 2% -0.3% 59.8% Stock Analytics
CIPLA ₹114,654.0 Cr 6% 2.8% 50.4% Stock Analytics
DIVIS LABORATORIES ₹104,348.0 Cr 3.7% 5.8% 17.3% Stock Analytics
ZYDUS LIFESCIENCES ₹101,499.0 Cr 2.6% 7.9% 94.3% Stock Analytics
DR REDDYS LABORATORIES ₹97,429.4 Cr -1.3% -2.8% 31.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-6.5%

-7.6%

57%

SENSEX

1.7%

-0.8%

19%


You may also like the below Video Courses